Back to search

Boston University

Developing a mouse model to study the metabolic role of the mammalian target of rapamycin complex 1 in adipose tissue

Abstract

dc:description.abstract

The term "diabesity" is a pandemic that is threatening populations worldwide and is the term is finding itself as a household name, fueling itself through the high-fat diet and sedentary lifestyle. As a result of these living choices, the population is suffering from lipotoxicity, the underlying cause of Type 2 Diabetes Mellitus (T2DM) and insulin resistance. Lipolytic control resides around the rate-limiting enzyme, adipose triglyceride lipase, which is normally downregulated in the insulin-stimulated state. This is the signal that is aberrant in patients who have T2DM and could be a significant factor in lipotoxicity. This state of lipotoxicity leads to many complications, increasing the risk of heart disease, heart attack, blindness, nephropathy, neuropathy, and stroke. Vasculature damage also can lead to poor perfusion of the lower extremities, increasing the risk of ulcer, gangrene, and amputation of the foot. An area of research delving into this issue lies within the mammalian target of rapamycin complex 1 (mTORC1), as it mediates the antilipolytic signal and decreases ATGL expression. This discovery was further clarified when the Kandror lab identified the transcription factor early growth factor 1 (Egr1) as the protein that binds to the promoter region of ATGL and downregulates its transcription. Egr1 has also been thought to be a factor in the development of insulin resistance in the hyperinsulemic state. To date, we have experimented upon murine 3T3-L1 and human adipocytes. We have developed a double transgenic mouse positive for reverse tetracycline transactivator (rtTA) and myc-tagged ras homolog enriched in brain (Rheb), which is a misnomer as it is located in adipose tissue (AT). With the mTORC1 axis hyperactive, we seek to show that Egr1 is a rich target in diabetes and lipotoxicity, regulating and inhibiting ATGL levels through mTORC1.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Thimmiah, Harun

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/14674

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Thimmiah, Harun. Developing a mouse model to study the metabolic role of the mammalian target of rapamycin complex 1 in adipose tissue. masters thesis, Boston University, 2014. https://hdl.handle.net/2144/14674